In an agency first, the FDA has cleared a system designed to clean out the complex inner channels of flexible endoscopes—a notorious source of hospital-acquired infections. Nanosonics ...
Beam Therapeutics (BEAM) announced that the FDA has cleared the investigational new drug application for BEAM-302 for the treatment of alpha-1 ...
On December 18, 2024, the Company announced the submission of its 510 (k) premarket notification to the U.S. Food and Drug Administration (FDA) for review and clearance of its Intelligent ...
Soleno Therapeutics' Vykat XR has become the first FDA-approved treatment for Prader ... Vykat XR (diazoxide choline) has been cleared to treat hyperphagia – an intense and incessant urge ...
LOS GATOS, CA - Tenon Medical, Inc. (NASDAQ:TNON), a micro-cap medical device company with a market capitalization of $3.14 million and impressive gross margins of 52%, has received FDA clearance ...
Health and Human Services Secretary Robert F. Kennedy Jr. and his allies rallied around removing industry influence from the Food and Drug Administration as part of their quest to Make America ...
Biomérieux SA recently received U.S. FDA 510(k) clearance for its Vitek Compact Pro, a system for microorganism identification and Antibiotic Susceptibility Testing. The company hopes that the system ...
Nanosonics has received FDA De Novo clearance for its new Coris system, a technology designed to improve the cleaning of flexible endoscopes and reduce infection risk, according to a March 20 news ...
The FDA’s IND clearance marks a significant milestone for Verve in its mission to advance gene editing therapies for cardiovascular diseases. While the company’s stock has faced challenges ...
(RTTNews) - Intelligent Bio Solutions (INBS),Tuesday announced that its FDA clearance process for the Intelligent Fingerprint Drug Screening System is progressing as planned, with the company on ...
According to GSK, the last time the FDA cleared a new class of antibiotics for uncomplicated UTIs was in 1996, with the approval of fosfomycin. (Last year, the agency approved the drug Pivya for ...
As of March 27, the outbreak had sickened 30 people, up from 28 a week ago. The FDA has not reported the age range of the patients or where they live. There are likely at least 60 patients in the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results